Toward the development of diagnostic assays to discriminate between Mycobacterium bovis infection and bacille Calmette-Guérin vaccination in cattle

Clinical Infectious Diseases

Volumn 30, Issue SUPPL. 3, 2000, Pages

  Vordermeier, H M ^a   Cockle, P J ^a   Whelan, A O ^a   Rhodes, S ^a   Hewinson, R G ^a  

^a VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; EPITOPE; GAMMA INTERFERON; MYCOBACTERIUM ANTIGEN;

ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; BCG VACCINATION; CATTLE DISEASE; CONFERENCE PAPER; DISEASE CONTROL; FEMALE; LYMPHOCYTE TRANSFORMATION; MYCOBACTERIOSIS; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BCG VACCINE; CATTLE; EPITOPES, T-LYMPHOCYTE; FEMALE; INTERFERON TYPE II; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; MYCOBACTERIUM BOVIS; RECOMBINANT PROTEINS; TUBERCULOSIS, BOVINE; VACCINATION;

EID: 0034465181     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313877     Document Type: Conference Paper

References (41)

1. Epidemiology of Mycobacterium bovis infection in animals and humans, with particular reference to Africa
2. Mycobacterium bovis in England and Wales: Past, present and future
3. HIV-related tuberculosis due to Mycobacterium bovis
4. The bovine tuberculosis cycle: An African perspective
5. Zoonotic tuberculosis due to Mycobacterium bovis in developing countries
6. Mycobacterium bovis infections in San Diego: A clinicoepidemiologic study of 73 patients and a historical review of a forgotten pathogen
7. Immunological responses and protection against Mycobacterium bovis in calves vaccinated with a low dose of BCG
8. Protection of cattle from bovine tuberculosis by vaccination with BCG by the respiratory or subcutaneous route, but not by vaccination with killed Mycobacterium vaccae
9. The immunity conferred by effective BCG and vole bacillus vaccines, in relation to individual variations in induced tuberculin sensitivity and to technical variations in the vaccines
10. Field experiment with BCG vaccine in Malawi
11. Physical mapping of Mycobacterium bovis BCG Pasteur reveals differences from the genome map of Mycobacterium tuberculosis H37Rv and from M. bovis
12. Delayed-type hypersensitivity to a recombinant mycobacterial antigen, MPB64, in guinea pigs sensitized to Mycobacterium tuberculosis or Mycobacterium bovis BCG
13. Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG
14. Molecular characterization of MPT83: A seroreactive antigen of Mycobacterium tuberculosis with homology to MPT70
15. Heterogenous expression of the related MPB70 and MPB83 proteins distinguish various substrains of Mycobacterium bovis BCG and Mycobacterium tuberculosis H37Rv
16. Serological reactivity to Mycobacterium bovis protein antigens in cattle
17. Cellular and humoral immune responses of cattle to purified Mycobacterium bovis antigens
18. Delayed-type hypersensitivity responses to ESAT-6 and MPT64 from Mycobacterium tuberculosis in the guinea pig
19. The potential of the ESAT-6 antigen secreted by virulent mycobacteria for specific diagnosis of tuberculosis
20. Experimental Mycobacterium bovis infection of cattle: Effect of dose of M. bovis and pregnancy on immune responses and distributions of lesions
21. Promiscuous T cell recognition of an H-2 I A-presented mycobacterial epitope
22. Multi-rod peptide synthesis strategy for T cell determinant analysis
23. T cell repertoire in tuberculosis: Selective anergy to an immunodominant epitope of the 38-kDa antigen in patients with active disease
24. Peptide specific response to M. tuberculosis: Clinical spectrum, compartmentalization and effect of chemotherapy
25. In vitro immunodiagnostic assays for bovine tuberculosis
26. Recognition of a common mycobacterial T-cell epitope in MPB59 of Mycobacterium bovis
27. An analysis of cellular proliferation, and synthesis of lymphokines and specific antibody in vitro by leucocytes from immunized cattle
28. Field comparison of the interferon-γ assay and the intradermal tuberculin test for the diagnosis of bovine tuberculosis
29. A field evaluation of serological and cellular diagnostic tests for bovine tuberculosis
30. New Zealand: Bovigam, it is official
31. Sensitivity and specificity of a gamma interferon blood test for tuberculosis infection
32. Soluble Mycobacterium bovis protein antigens: Studies on their purification and immunological evaluation
33. Use of Mycobacterium tuberculosis complex-specific antigen cocktails for a skin test specific for tuberculosis
34. Differentiation between Mycobac terium bovis BCG-vaccinated and M. bovis-infected cattle using recombinant mycobacterial antigens
35. T-cell recognition of mycobacterial antigens
36. Identification of bovine T-cell epitopes for three Mycobacterium bovis antigens: MPB70, 19,000 MW and MPB57
37. Peptide mapping of bovine T-cell epitopes for the 38 kDa tuberculosis antigen
38. Differential T cell responses to Mycobacterium tuberculosis ESAT6 in tuberculosis patients and healthy donors
39. Key epitopes on the ESAT-6 antigen recognized in mice during the recall of protective immunity to Mycobacterium tuberculosis
40. T cell responses to a mixture of Mycobacterium tuberculosis peptides with complementary HLA-DR binding profiles